Suppression of tumour growth by orally administered osteopontin is accompanied by alterations in tumour blood vessels

摘要

Background: The integrin-binding protein osteopontin is strongly associated with tumour development, yet is an abundant dietary component as a constituent of human and bovine milk. Therefore, we tested the effect of orally administered osteopontin (o-OPN) on the development of subcutaneous tumours in mice.